Browsing: Fund

Aug. 19, 2026 (GLOBE NEWSWIRE) — Carlyle Credit Income Fund (“we,” “us,” “our,” “CCIF” or the “Fund”) (NYSE: CCIF) today announced its financial results for its third quarter ending June 30, 2026. The full detailed presentation of the Fund’s third quarter 2026 financial results can be viewed on the Fund’s website ( https://www.carlylecreditincomefund.com/investor-dashboard )

Reach Capital has raised $265 million for its fifth flagship fund, giving the early-stage venture capital firm fresh capital to invest in another 50 founding teams while bringing its assets under management close to $1 billion.

BrknPar Venture Fund today announced that former Major League Baseball standouts Jon Jay and Tyson Ross have joined the firm as Athlete Venture Partners (AVPs). Both have invested alongside BrknPar and will play active roles in sourcing investment opportunities, evaluating prospective investments, supporting portfolio companies, and expanding the firm’s strategic network across the sports technology…

Reach Capital announced Tuesday the close of a $265 million Fund V. The thesis of the 11-year-old, San Francisco firm is to back founders building AI applications that can “expand human potential,” Tony Wan, head of platform at Reach Capital, told TechCrunch. In practice, he added, that means looking at founders building across three areas:…

Underneath the surface, there are ‘big movements’ happening in the nation’s superannuation and retirement industries.

NUtech Ventures is launching the Innovation Advancement Fund, a proof-of-concept funding program designed to help move promising university research from the laboratory toward commercialization.

The Saudi investment firm’s new fund will back growth-stage technology companies through primary rounds and secondary transactions.

As if the vast scale of artificial intelligence (AI) investments wasn’t scary enough, the head of the world’s largest sovereign wealth fund is also sounding the alarm.

The Bad Homburg vor der Höhe-based healthcare group’s fund comes as Europe’s biopharma dealmaking community prepares to descend on Cologne, Germany, forBIO-Europein November.

The venture firm’s fifth fund would push total capital raised from limited partners above $4 billion